Table 2.
Summary of adverse events (safety analysis set; N = 6)
Event, n | Subject, n (%) | |
---|---|---|
Adverse event | 4 | 4 (66.7) |
Breath odor | 4 | 4 (66.7) |
Drug‐related adverse event | 4 | 4 (66.7) |
Breath odor | 4 | 4 (66.7) |
Serious adverse event | 0 | 0 |
Drug‐related serious adverse event | 0 | 0 |
Adverse event leading to discontinuation | 0 | 0 |
Drug‐related adverse event leading to discontinuation | 0 | 0 |